Endurant Capital Management’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-145,380
Closed -$596K 83
2021
Q3
$596K Sell
145,380
-15,311
-10% -$62.8K 0.14% 50
2021
Q2
$845K Buy
+160,691
New +$845K 0.23% 54